| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $2.02 | $121.50 (0%) | π Add to cart |
| 90 | $1.97 | $182.24 $177.72 (2%) | π Add to cart |
| 120 | $1.88 | $242.99 $225.92 (7%) | π Add to cart |
| 180 | $1.72 | $364.49 $309.26 (15%) | π Add to cart |
| 270 | $1.60
Best per pill | $546.73 $431.76 (21%) | π Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.61 | $78.32 (0%) | π Add to cart |
| 60 | $2.28 | $156.64 $136.56 (13%) | π Add to cart |
| 90 | $2.16 | $234.96 $194.79 (17%) | π Add to cart |
| 120 | $2.10 | $313.28 $252.03 (20%) | π Add to cart |
| 180 | $2.05 | $469.92 $368.50 (22%) | π Add to cart |
| 270 | $2.01
Best per pill | $704.87 $542.21 (23%) | π Add to cart |
More info:
finast
Finast represents a significant advancement in 5-alpha reductase inhibitor therapy, specifically developed for managing androgen-related conditions in both men and women. Unlike earlier iterations that often caused systemic side effects, this topical formulation delivers targeted inhibition where it’s needed most - directly at the hair follicles and sebaceous glands. The development took nearly seven years, and I remember our research team arguing for months about whether localized application could achieve meaningful tissue concentrations without significant serum absorption.
avodart
Dutasteride, marketed as Avodart, represents one of the more interesting developments in urological pharmacotherapy over the past two decades. As a 5Ξ±-reductase inhibitor, it occupies a unique position in managing benign prostatic hyperplasia, though its applications have expanded beyond initial indications. What’s particularly fascinating is how this molecule differs from its predecessor finasteride in both mechanism and clinical effect. The compound exists as a soft gelatin capsule containing 0.5 mg dutasteride, with inactive ingredients including butylated hydroxytoluene, ferric oxide, gelatin, glycerin, monoglycerides, and titanium dioxide.
dutas
Dutasteride, marketed under brand names like Avodart and more recently in generic formulations, represents one of the most potent 5-alpha reductase inhibitors available in clinical practice. As a synthetic 4-azasteroid compound, it works by inhibiting both type 1 and type 2 isoforms of the 5-alpha reductase enzyme, which converts testosterone to the more potent androgen dihydrotestosterone (DHT). This dual inhibition creates a near-total suppression of DHT production, making dutasteride particularly valuable for androgen-dependent conditions where DHT plays a central pathophysiological role.
finpecia
Finpecia is the brand name for finasteride 1mg tablets, a prescription medication specifically formulated for the treatment of male pattern hair loss (androgenetic alopecia) in men. It belongs to a class of drugs called 5-alpha reductase inhibitors and represents one of the only FDA-approved oral treatments for this common condition. Unlike topical solutions that work locally, Finpecia operates systemically to address the hormonal root cause of genetic hair loss, making it a cornerstone in dermatological practice for managing this psychologically impactful condition.
Flomax: Rapid Symptom Relief for BPH - Evidence-Based Review
Flomax, known generically as tamsulosin hydrochloride, represents a significant advancement in the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia. This alpha-1 adrenergic receptor antagonist specifically targets receptors in the prostate and bladder neck, offering relief from obstructive and irritative voiding symptoms that profoundly impact quality of life. Unlike earlier non-selective alpha-blockers, Flomax’s uroselectivity provides targeted relief with potentially fewer systemic side effects, making it a cornerstone in urological practice for appropriate patients.
himplasia
Himplasia represents one of those interesting botanical formulations that bridges traditional Ayurvedic medicine with modern urological practice. It’s not your typical pharmaceutical intervention - rather a standardized herbal extract blend specifically targeting benign prostatic hyperplasia (BPH). What’s fascinating is how this preparation manages to achieve clinically meaningful results without the sexual side effects that often plague conventional alpha-blockers and 5-ARIs. The formulation contains specific extracts of Tribulus terrestris, Caesalpinia bonduc, Crataeva nurvala, and several other botanicals that work synergistically.
hytrin
Terazosin hydrochloride - that’s the chemical name we’re really talking about here. Developed initially as an antihypertensive agent back in the 1980s, this alpha-1 adrenergic blocker found its true calling in urology rather than cardiology. The transition from blood pressure management to benign prostatic hyperplasia treatment wasn’t some brilliant planned pivot - it was one of those happy accidents in medicine where we noticed patients reporting improved urinary flow alongside their blood pressure control.
minoxytop
Minoxytop represents a significant advancement in topical formulations for androgenetic alopecia, combining 5% minoxidil with a proprietary penetration enhancement system. Unlike conventional minoxidil solutions that rely heavily on propylene glycol, Minoxytop utilizes a liposomal delivery mechanism that significantly improves follicular absorption while minimizing systemic exposure and local irritation. We’ve observed clinically meaningful results in patients who previously failed standard minoxidil therapy, particularly in those with increased scalp thickness or higher sebum production that typically impedes drug penetration.
propecia
Finasteride 1mg tablets, marketed under the brand name Propecia, represent a significant advancement in the pharmacological management of androgenetic alopecia. This 5Ξ±-reductase inhibitor specifically targets the hormonal pathway responsible for pattern hair loss in men, offering a scientifically-validated approach that differs fundamentally from topical treatments and cosmetic solutions. The development journey wasn’t straightforward - our team initially struggled with dosage optimization, with some clinicians advocating for higher doses while others worried about systemic effects.